Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement
By I. Müller, F. Besta, C. Schulz, Steffen Massberg, A. Schönig, M. Gawaz. Thrombosis and Haemostasis, 2003
641 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/1373f001415178976e52b6000dc9bb516bd87f50
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Gregg Stone
- S. Silber
- P. Albertsson
- P. Camici
- A. Colombo
- F. F. Avilés
- W. Wijns
- P. Teirstein
Citations in the corpus
- Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. (2005, background): “The emerging question about possible clopidogrel resistance requires more investigation.(225,226)”
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. (2008, methodology): “The wide inter-individual variability in the inhibitory effect of clopidogrel has been well described.(1,4,31) We performed an ROC analysis on a cohort of patients undergoing PCI with DES to (i)”